Carillon Tower Advisers’s Core Laboratories CLB Stock Holding History

Carillon Tower Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.02M	Sell	38,310 -2,279	-6%	-$46.5K	0.01%	469
2020 Q3	$619K	Sell	40,589 -1,418	-3%	-$29.7K	0.01%	437
2020 Q2	$854K	Sell	42,007 -742	-2%	-$13.3K	0.01%	458
2020 Q1	$442K	Sell	42,749 -3,771	-8%	-$105K	﹤0.01%	439
2019 Q4	$1.75M	Sell	46,520 -1,500	-3%	-$67.4K	0.01%	463
2019 Q3	$2.24M	Sell	48,020 -375	-0.8%	-$17.4K	0.02%	461
2019 Q2	$2.53M	Buy	48,395 +950	+2%	+$55.7K	0.02%	445
2019 Q1	$3.27M	Buy	+47,445	New	+$3.18M	0.02%	419
2018 Q2	–	Sell	-24,651	Closed	-$2.62M	–	468
2018 Q1	$2.62M	Sell	24,651 -5,746	-19%	-$636K	0.02%	420
2017 Q4	$3.33M	Buy	+30,397	New	+$3.03M	0.04%	240

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Carillon Tower Advisers's CLB Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Core Laboratories (CLB) stake by 5.6% in Q4 2020, selling an estimated $46.5K and leaving 38,310 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #469.

Carillon Tower Advisers first reported a position in CLB in Q4 2017 and has held it in 10 quarters since. The position peaked at $3.33M in Q4 2017. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

Carillon Tower Advisers held 38,310 shares of Core Laboratories worth $1.02M as of Q4 2020.
Carillon Tower Advisers sold 2,279 Core Laboratories shares in Q4 2020, an estimated $46.5K.
Core Laboratories made up 0.01% of Carillon Tower Advisers's portfolio in Q4 2020, its #469 holding.
Carillon Tower Advisers first reported a position in Core Laboratories in Q4 2017 and has held it in 10 quarters since.
Carillon Tower Advisers's Core Laboratories position peaked at $3.33M in Q4 2017.
181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.